课题基金 / 基金详情

Structure and Function of the Death Effector FADD

Structure and Function of the Death Effector FADD
死亡效应器FADD的结构和功能
批准号:
6436214
负责人:
Milton H. Werner
金额:
$24.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-01 至 2006-05-31

项目摘要

项目成果

Milton H. Werner的其他基金

相似基金

相关文献

中文摘要
翻译
这项提议将研究肿瘤坏死因子受体家族(TNFR)的一个亚类,称为死亡受体(DRS),如何在细胞质表面组装一个立体特异性复合体来启动细胞程序性死亡(PCD)。DRS的C-末端结构域由一个保守的六螺旋束组成,称为死亡结构域(DD)。DD形成多蛋白复合体的核,围绕该复合体,PCD机制的酶和调节组件聚集在一起,将死亡刺激转化为生化反应。DDS既存在于受体中,也存在于其调节成分中,也就是。死亡情结的死亡效应器。几乎所有的死亡信号都是通过FADD传递的。在配体结合时,死亡受体招募FADD和启动子caspase,即FLICE/caspase-8,以启动PCD。FADD由两个蛋白质相互作用基序组成,即DD和第二个被称为死亡效应结构域(DED)的基序。为了定义死亡受体/FADD相互作用的架构,FADD(208A.A.)的三维结构。将在溶液中确定,其与三种死亡受体-Fas、DR5和DR3的结合面将通过体外信号复合体的定点突变和重组来鉴定。初步的结构和生化实验表明,Fas/FADD的相互作用依赖于FADD的DD和DED结构域,沿着穿过这两个结构域的连续表面。这一表面与果蝇管的DD相互作用表面非常相似,果蝇管是一种与PCD无关的含有DD的蛋白质。这表明含DD蛋白的结合机制是保守的。一种新的死亡受体模拟物已经被合成来在体外重建信号复合体。这种模拟将被用来结合凝胶过滤、分析离心和突变来鉴定所有三种死亡受体/FADD相互作用的结合表面和特异性决定因素。FLICE/caspase-8重新聚集到受体/FADD复合体的分子机制也有待确定,并提供了初步证据来定义Flice/caspase-8的FADD结合表面。最后,将对FADD功能的大脑特异性拮抗剂PEA-15的作用进行表征。将确定PEA-15的结构及其与信号复合体中FADD的结合机制。这些努力的总和将为死亡诱导信号复合体的体系结构提供第一个全面的图景。这项研究的结果可以为理解不同的死亡受体如何使用它们的同源效应器来激活特定的死亡反应奠定基础。
英文摘要
This proposal will investigate how a subclass of the tumor necrosis factor receptor family (TNFRs), termed death receptors (DRs), assembles a stereospecific complex at the cytoplasmic surface to initiate programmed cell death (PCD). The C-terminal domain of DRs is composed of a conserved six helix bundle known as the death domain (DD). The DD forms the nucleus of a multiprotein complex about which the enzymatic and regulatory components of the PCD machinery assemble to transduce a death stimulus into a biochemical response. DDs are present in both the receptor and its regulatory components, a.k.a. death effectors, of the death complex. The death effector through which nearly all death signals proceed is FADD. Upon ligand binding, a death receptor recruits FADD and the initiator caspase, FLICE/caspase-8, to initiate PCD. FADD is comprised of two protein interaction motifs, the DD and a second motif known as the death effector domain (DED). To define the architecture of death receptor/FADD interaction, the three dimensional structure of FADD (208 a.a.) is to be determined in solution and its binding surfaces for three death receptors-Fas, DR5 and DR3- are to be identified by site-directed mutagenesis and reconstitution of the signaling complex in vitro. The preliminary, structure and biochemical experiments demonstrate that the Fas/FADD interaction is dependent on both the DD and DED domains of FADD along a contiguous surface which traverses both domains. This surface is remarkably similar to the DD interaction surface of Drosophila Tube, a DD-containing protein unrelated to PCD. This suggests that the binding mechanism of DD-containing proteins is conserved. A novel death receptor mimic has been synthesized to reconstitute the signaling complex in vitro. This mimic will be used to identify the binding surfaces and specificity determinants for all three death receptor/FADD interactions using a combination of gel filtration, analytical centrifugation and mutagenesis. The molecular mechanism for FLICE/caspase-8 recruitment into the receptor/FADD complex is also to be determined and preliminary evidence is presented to define the FADD binding surface for FLICE/caspase-8. Finally, the action of a brain-specific antagonist of FADD function, PEA-15, will be characterized. The structure of PEA-15 and its binding mechanism to FADD in the signaling complex will be determined. The sum of these efforts will provide the first comprehensive picture of the architecture of a death-inducing signaling complex. The outcome of this study can form the basis for understanding how different death receptors use their cognate effectors to activate a specific death response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kinase activation in multiple system atrophy
  • 批准号:
    10252219
  • 项目类别:
  • 资助金额:
    $38.59万
  • 财政年份:
    2021
  • 负责人:
    Milton H. Werner
  • 依托单位:
Advanced therapeutic for Parkinson's Disease
  • 批准号:
    10020202
  • 项目类别:
  • 资助金额:
    $154.67万
  • 财政年份:
    2017
  • 负责人:
    Milton H. Werner
  • 依托单位:
DFG-out inhibitors of Abl-kinases to treat PML
  • 批准号:
    8586614
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2013
  • 负责人:
    Milton H. Werner
  • 依托单位:
PML antiviral for AIDS
  • 批准号:
    7842285
  • 项目类别:
  • 资助金额:
    $26.58万
  • 财政年份:
    2009
  • 负责人:
    Milton H. Werner
  • 依托单位:
海外基金